A Randomized Phase II Study of Imetelstat (GRN163L) in Combination with Paclitaxel (with or without Bevacizumab) in Patients with Locally Recurrent or Metastatic Breast Cancer
K
Kathy Miller, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Not Recruiting
18 years - 100 years
All
Phase
N/A
1 Location
Brief description of study
The main purpose of this research study is to see if an investigational drug, imetelstat sodium for injection, combined with standard treatment can prevent breast cancer from getting worse compared to standard treatment alone.
Detailed description of study
The main purpose of this research study is to see if an investigational drug, imetelstat sodium for injection, combined with standard treatment can prevent breast cancer from getting worse compared to standard treatment alone.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Breast Cancer
-
Age: 18 years - 100 years
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 1105005390
